The first AI-powered video management and analytics platform for
the OR, Touch Surgery Enterprise gives surgical teams easy access
to procedural videos and insights
DUBLIN, March 9, 2022 /PRNewswire/ -- Medtronic plc
(NYSE: MDT), a global leader in healthcare technology, today
announced it has entered into a contract with Vizient, a leading
healthcare performance improvement company in the U.S., to add
Touch Surgery™ Enterprise to Vizient's offerings, which serve more
than half the nation's healthcare providers.
The first AI-powered surgical video management and analytics
platform for the operating room (OR), Touch Surgery Enterprise
significantly simplifies the process of recording, analyzing, and
sharing surgical video — providing surgeons with a powerful new
tool to improve performance and train others.1,†
A fully integrated hardware and software system connected to the
cloud, Touch Surgery Enterprise works easily with many laparoscopic
and robotic scopes, enabling hospitals to take the first step to
digitizing their OR while leveraging existing equipment.
"Touch Surgery Enterprise allows surgeons to use data to refine
the way surgery is taught and executed, and we believe that will
raise the standard of healthcare for all," said George Murgatroyd, vice president and general
manager, Digital Surgery within the Surgical Robotics business,
which is part of the Medical Surgical Portfolio of Medtronic. "This
agreement with Vizient allows us to build on the strong interest
we're seeing globally, to support hospitals in the U.S. who are
looking to harness the power of surgical video data and
analysis."
Touch Surgery Enterprise is part of Medtronic's growing
portfolio of artificial intelligence (AI) and surgical robotic
solutions. It is compatible with the Hugo™ robotic-assisted surgery
(RAS) system.‡
Vizient contract provides access to a nationwide network of
hospitals
Vizient serves more than half the nation's acute
care providers, including academic medical centers, community
hospitals, pediatric facilities, and non-acute care providers.
"Vizient's mission is to help our member providers deliver high
value care to the patients they serve. Our ability to evolve
relationships with our suppliers is a critical piece to the
equation as we look to deliver on a more comprehensive value
proposition in the market," said Bryan
Grossman, senior vice president, Strategic Supplier
Performance & Category Management, Vizient. "Touch Surgery
Enterprise aligns with our mission, offering our members the
ability to analyze surgical processes that can help advance patient
care."
AI-powered surgical video and data available anytime,
anywhere
Touch Surgery Enterprise is comprised of the DS1
computer and controller — surgical video recording hardware
designed specifically for the OR. Applications of built-in AI
include:
- Automatic blurring of faces and protected information to ensure
data privacy compliance before uploading surgical video to the AWS
global cloud
- Automatic segmentation of surgical video into key procedural
steps for a growing library of procedures
- Ability to benchmark a case against a bank of historical cases
or make comparisons across departments
All videos are accessed through the Touch Surgery™ App, which is
free to download and home to academically validated and accredited
simulations for mobile training on 200+ procedures in 17+
specialties. With 2.5 million active users, the app allows surgeons
to prepare, practice, and teach surgical procedures — anytime,
anywhere.
"By simplifying the process to capture and analyze surgical
video, Touch Surgery Enterprise gives surgical teams a powerful new
tool to advance patient care," said Megan
Rosengarten, president of the Surgical Robotics business at
Medtronic. "We're excited about the impact it can make for
customers today, as a solution for laparoscopic and
robotic-assisted cases within their existing infrastructure, and
for the possibility this technology creates in the future."
†Touch Surgery Enterprise is not intended to analyze medical
images or signals to guide surgery, or aid in diagnosis or
treatment of a disease or condition. It is available in most
markets around the world, including in the U.S.
‡The Hugo RAS system is commercially available in certain
geographies. Regulatory requirements of individual countries and
regions will determine approval, clearance, or market availability.
In the EU, the Hugo RAS system is CE marked. In Canada, the
Hugo RAS system has a medical device license. The Hugo RAS system
is approved in Australia. In the U.S., the Hugo RAS system is
an investigational device not for sale.
For more information about Touch Surgery Enterprise, visit our
website.
About Medtronic
Bold thinking. Bolder actions. We are
Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global
healthcare technology company that boldly attacks the most
challenging health problems facing humanity by searching out and
finding solutions. Our Mission — to alleviate pain, restore health,
and extend life — unites a global team of 90,000+ passionate people
across 150 countries. Our technologies and therapies treat 70
health conditions and include cardiac devices, surgical robotics,
insulin pumps, surgical tools, patient monitoring systems, and
more. Powered by our diverse knowledge, insatiable curiosity, and
desire to help all those who need it, we deliver innovative
technologies that transform the lives of two people every second,
every hour, every day. Expect more from us as we empower
insight-driven care, experiences that put people first, and better
outcomes for our world. In everything we do, we are engineering the
extraordinary. For more information on Medtronic (NYSE:MDT), visit
www.Medtronic.com and follow @Medtronic on Twitter and
LinkedIn.
Any forward-looking statements are subject to risks and
uncertainties such as those described in Medtronic's periodic
reports on file with the Securities and Exchange Commission. Actual
results may differ materially from anticipated results.
1. Based on a randomized controlled trial using porcine models:
Singh P, Aggarwal R, Tahir M, Pucher PH, Darzi A. A randomized
controlled study to evaluate the role of video-based coaching in
training laparoscopic skills. Ann Surg.
2015;261(5):862–869.
Contacts:
|
|
Gary
Jeanfaivre
|
Ryan
Weispfenning
|
Public
Relations
|
Investor
Relations
|
+1-203-833-2104
|
+1-763-505-4626
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/medtronic-announces-contract-with-vizient-for-touch-surgery-enterprise-301498339.html
SOURCE Medtronic plc